Douglas Slain

Professor

West Virginia University

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Douglas Slain is a Professor at West Virginia University in the United States. His research areas focus on antimicrobial resistance, particularly in Enterobacterales, and pharmacotherapeutic strategies for diverse infections. Recent articles authored by Professor Slain explore topics such as the effectiveness of β-lactam antibiotics, the role of pharmacists in antimicrobial stewardship, and the complexities of antibiotic therapy in clinical settings.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Todd Brothers

Clinical Assistant Professor

University of Rhode Island

UNITED STATES

View details

Khaled Shawwa

Assistant Professor

West Virginia University

UNITED STATES

View details

Sijin Wen

Associate Professor with tenure

West Virginia University

UNITED STATES

View details

Amy Seybert

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Douglas Slain

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales

A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales

Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians

The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States

The top 10 papers on the treatment of invasive fungal infections, 2018–2023

Serratia endocarditis: antimicrobial management strategies and clinical outcomes

Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison

Pharmacists’ roles in antimicrobial stewardship: “All hands on deck”

Evaluating the Medication Regimen Complexity Score as a Predictor of Clinical Outcomes in the Critically Ill

Adapting the layered learning model to a virtual international exchange program

An Antimicrobial Treatment Assessment of Serratia marcescens Bacteremia and Endocarditis

Characteristics and predictors of patient care performed by clinical department chairpersons at U.S. schools of pharmacy

A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2020

Impact of anti‐anaerobic antibiotic activity on graft‐versus‐host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling

Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza

1457. Serial Passage of Enterobacteriaceae to Explore Development of Carbapenem Resistance

Collaborators (4)

Todd Brothers

Khaled Shawwa

Sijin Wen

Amy Seybert

Make your next move.